Heidi Cuthbert

Pfizer (NYSE:PFE) announced unprecedented seven-year follow-up results from its Phase 3 CROWN trial, revealing that its oncology drug Lorbrena significantly extended progression-free survival in patients with a specific, aggressive form of lung cancer.

International Flavors & Fragrances (NYSE:IFF) agreed to sell its Food Ingredients division to funds advised by CVC Capital Partners in a transaction valuing the unit at approximately $4.3 billion.

Natera (NASDAQ:TRA) has entered into a clinical collaboration with Diakonos Oncology to deploy its liquid biopsy technology to track patient responses during an active trial for an aggressive skin cancer therapy.

LayerZero’s ZRO token remains under pressure after recording one of the sharpest declines in the crypto market, with multiple indicators pointing to weakening demand and growing selling activity.

Sui Network resumed normal operations after a network outage lasting nearly six hours that temporarily halted transaction processing across its mainnet.

Six major battery storage projects have secured state government contracts under the first round of South Australia’s Firm Energy Reliability Mechanism programme.

Aave Labs’ Push has secured cryptoasset registration from the UK Financial Conduct Authority, enabling it to conduct certain regulated activities and advance its stablecoin infrastructure plans.

1414 Degrees (ASX:14D) launched the scale-up phase of its SiNTL silicon nanoparticle anode programme.

Grayscale Investments has spotlighted Hyperliquid as one of the crypto industry's breakout success stories, highlighting the decentralised trading platform's rapid growth and expanding role in digital asset markets.

Marvel Gold (ASX:MVL) commenced its reverse circulation drilling programme at the 100%-owned Hanang Gold Project.